Veozah Prior Authorization: What Your Insurance Needs to Approve It

The HRT Index Editorial TeamIndependent women's health research

Published: May 15, 2026Last reviewed: June 16, 2026

Editorial research — not medically reviewed by a clinician. Why this label

By The HRT Index Editorial Team · Last verified: June 16, 2026

The HRT Index is an independent comparison resource for HRT telehealth providers. Some links below are affiliate links — if you start care through one, we may earn a commission, at no extra cost to you. Manufacturer and patient-assistance links are not affiliate links. Provider fit and your safety come first.

Your doctor said yes. Your insurance said “not so fast.”

If you’re staring at a “prior authorization required” message — or a price near $584 at the pharmacy — here’s the short version. Veozah prior authorizationis usually a paperwork match: your prescriber has to show your plan that you have moderate-to-severe menopausal hot flashes or night sweats, that you’ve tried other treatments or can’t take them, and that your liver labs are within the limits the drug’s label sets. Decisions often take a few days to a week (around 72 hours for urgent requests on Medicare Part D).

This is fixable far more often than it feels right now. Below, we’ll show you the pattern hiding inside ten insurers’ actual rules — and the appeal steps that answer a denial head-on instead of just repeating it.

One honest thing up front

No guide can promise your plan will approve Veozah. Some plans exclude it. Some make you try hormone therapy first. And some bounce a request because one piece of paperwork was missing. That last one is fixable — which is exactly why this guide starts with finding your exact rejection reason instead of guessing.

Before your doctor’s office sends anything, here’s what most plans want to see

What your plan may ask for	What to have ready
Diagnosis	Moderate-to-severe hot flashes/night sweats due to menopause
Symptom proof	How often, how bad, sleep loss, how long it’s lasted
Prior treatment	What you tried, what failed — or why hormone therapy isn’t right for you
Liver labs	ALT, AST, ALP, and bilirubin (standard liver blood tests)
Safety screen	No cirrhosis, severe kidney disease, or interacting medicines
Dose	Veozah 45 mg, one tablet daily

What we checked to write this

We read and confirmed the FDA’s prescribing information and Boxed Warning, Astellas’s official price and savings terms, and the prior-authorization criteria from ten real payers— including CVS Caremark, UnitedHealthcare, Prime Therapeutics, a TRICARE plan, and five state Medicaid programs. Every number below is sourced, and the full list is at the bottom of this page.

First, is Veozah even hormone therapy? (It’s not — and that matters here)

Veozah (fezolinetant) is not hormone therapy.It’s a non-hormonal pill — the first in a class called NK3 receptor antagonists, which calm the brain signal that sets off hot flashes. It’s FDA-approved for moderate-to-severe vasomotor symptoms (the medical term for hot flashes and night sweats) caused by menopause. We cover it here because it’s the main non-hormonal option people weigh against, or alongside, HRT. See our full comparison: Veozah vs. HRT.

Why does this matter for your prior authorization? Because many plans treat Veozah as a step up from cheaper options. As you’ll see in our table below, 7 of the 10 plans we read make you try another treatment first. Walk in knowing that, and you can get ahead of it.

Does Veozah usually need prior authorization?

Yes — most plans require prior authorization before they’ll pay for Veozah. It’s a brand-only drug with no generic and a list price of $583.50 a month as of January 2026, so insurers put a gate in front of it. Many plans also add step therapy (trying another treatment first), and some don’t cover it at all. Your first move is to ask your plan for the exactreason your claim was rejected — because that reason decides everything you do next.

Here’s what most people don’t realize: “I got denied” can mean six very different things.

“Not covered” is not the same as “denied”

What you heard	What it usually means	What to do
Prior authorization required	No request was sent, or it was incomplete	Get your plan’s Veozah PA form to your prescriber
Step therapy required	The plan wants proof you tried something first	Document what you tried, or why you can’t take it
Non-formulary / not covered	Veozah isn’t on your plan’s drug list	Ask about a formulary exception (a different process)
Not medically necessary	The request didn’t match the plan’s rules	Send a Letter of Medical Necessity plus chart notes
Missing information	The office left out labs, a code, or notes	Find the one missing piece and resend
Quantity limit	The plan covers less than what was prescribed	Confirm the dose is one tablet a day

Don’t appeal anything until you know which one you’re dealing with. Appealing the wrong reason just burns weeks.

The 30-second call that saves you weeks

Call the member number on your insurance card and say this, word for word:

“My doctor prescribed Veozah 45 milligrams. Can you tell me the exact reason the claim was rejected? Is it prior authorization, step therapy, non-formulary, a quantity limit, or missing information? And where should my prescriber send the form?”

Write the answer down. That one call is the difference between guessing and knowing — and it costs you nothing but five minutes. Make it before you do anything else on this page.

What does insurance actually need to approve Veozah?

Across the ten payer policies we read, approval almost always comes down to a short list: a documented diagnosis of moderate-to-severe menopausal hot flashes; on many plans, proof you tried hormone therapy or can’t take it; recent liver labs within the label’s limits; no disqualifying health conditions; and a dose of one tablet a day. Plans that look strict are usually just asking for these in writing.

Think of it as a packet. The more of it your doctor sends the first time, the faster you get a “yes.”

Your doctor-ready Veozah packet checklist

Copy this and send it to your prescriber’s office before they submit:

1Diagnosis: Moderate-to-severe vasomotor symptoms (hot flashes/night sweats) due to menopause — not just “hot flashes”
2Symptom details: How often, how bad, night sweats, sleep loss, how long it’s been going on
3Prior treatments: What you tried, what didn’t work, what you couldn’t tolerate — or a clear medical reason hormone therapy isn’t right for you
4Baseline liver labs: ALT, AST, ALP, and bilirubin (total and direct), plus a plan for follow-up testing
5Medication list: So they can check for interacting drugs (especially CYP1A2 inhibitors)
6Health screen: Confirming no cirrhosis, severe kidney disease, or end-stage kidney disease
7Dose: Veozah 45 mg, one tablet daily
8Diagnosis code: ICD-10 code N95.1 (“menopausal and female climacteric states”) — your prescriber handles the coding, but it helps to know it

A packet that spells out “moderate-to-severe VMS due to menopause, 8 episodes a day, tried estradiol with an inadequate response, baseline liver labs below the label’s limits, monitoring plan in place” gives the reviewer nothing to push back on. A packet that just says “hot flashes” gets kicked back. Same drug, same patient — different outcome, decided by the paperwork.

Veozah prior authorization criteria by insurer: the pattern nobody else lays out

The exact rules vary by plan, but the pattern is remarkably consistent. Plans want the diagnosis, a reason Veozah is necessary, proof your liver is safe to start, and a dose that matches the label. The strictest plans add step therapy — sometimes asking you to try both hormone therapy and an older non-hormonal medicine. Below is what ten payers actually require, pulled straight from their own policy documents.

This is the part you’d otherwise have to dig out of ten separate PDFs written for doctors. We did the digging.

Insurer (plan type)	First approval	Try another treatment first?	Liver labs?	Other details worth knowing	Source checked
Prime Therapeutics / Accord (commercial)	3 months	Yes — both a hormone therapy and a non-hormonal drug (with exceptions, like being over 60)	Yes — under 2× the normal limit before starting	Defines “moderate-to-severe” as 7+ hot flashes a day or 50+ a week; renews 12 months; 30 tablets per 30 days	Prime policy, eff. Jan 1, 2026
CVS Caremark (commercial / PBM)	12 months	Not stated in the criteria we read	Not specified in the criteria we read	30 tablets per 25 days; renewal needs a positive response	CVS Caremark criteria
UnitedHealthcare (commercial)	12 months	Yes — a 30-day fail, intolerance, or contraindication to one therapy	Yes — baseline, plus periodic labs to renew	Renewal needs proof it’s working	UnitedHealthcare commercial policy
Western Health Advantage	6 months	Yes — one hormone therapy or one non-hormonal option	Yes — ALT, AST, bilirubin under 2× normal	Reauthorization about 6 months with a good response	Western Health Advantage criteria
US Family Health Plan (a TRICARE plan)	6 months	Yes — can’t-take-HRT plus a tried-and-failed SSRI, SNRI, or gabapentin	Yes — provider confirms the full monitoring schedule	Renewals approve indefinitely after the first approval	Johns Hopkins USFHP PA form
Alaska Medicaid	Up to 3 months	Yes — failed one category, or can’t take both	Yes — baseline + monitoring	34 tablets per 34 days; renews up to 12 months	Alaska Medicaid criteria
West Virginia Medicaid	90 days	Yes — a 30-day HRT trial plus a 30-day non-hormonal trial	Yes — baseline, then monthly ×3, then months 6 and 9	Renewal up to 1 year with a good response	West Virginia Medicaid criteria
Mississippi Medicaid	6 months	Yes — 30-day trial of one hormone and one non-hormonal	Yes — baseline + the full monitoring schedule	Renews 12 months with a positive response	Mississippi Medicaid criteria
Minnesota Medicaid	3 months	Not shown in the criteria we read	Yes — bilirubin, ALT, AST under 2× normal	34 tablets per 34 days; renews 12 months	Minnesota Medicaid criteria
Texas Medicaid	180 days	No step therapy	Yes — a liver panel within the last 90 days	Approves with a menopause diagnosis on file, no cirrhosis/severe kidney disease, no interacting drug, one tablet a day	Texas Medicaid (Acentra) criteria

Policies vary by individual plan and change over time. Confirm your exact plan’s rules using the matching source listed at the bottom of this page. Last verified June 16, 2026.

What the pattern tells you

Read down that table and three things jump out — and these counts come straight from our own review of the ten policies:

10 of 10 gate Veozah

Every one of the ten gates Veozah behind prior authorization, criteria, or a quantity limit. None of them just pay it automatically. So expect a step, whoever your insurer is.

7 of 10 have step therapy

Step therapy is the big divider. 7 of the 10 make you try another treatment first — and a few (Prime, West Virginia, Mississippi, TRICARE) want you to have tried two kinds. The other 3 (CVS, Minnesota, and current Texas Medicaid) didn’t show a step in the criteria we read. Knowing which camp your plan is in tells you whether you need a “tried and failed” history in your packet.

9 of 10 require liver labs

Liver labs are nearly universal — 9 of the 10 require them. That’s not busywork; it ties directly to Veozah’s safety warning. Getting your baseline labs done before the request goes in removes one of the most common reasons a request stalls.

And notice the approval lengths: most first “yes” answers run 3 to 6 months, with a couple at 12 months and Texas at 180 days. Almost all renewals depend on proof it’s working. So track your hot flashes from day one— you’ll need that number later.

What liver tests and safety details matter for approval?

FDA Boxed Warning — the agency’s most serious warning

Veozah carries an FDA Boxed Warning for rare but serious liver injury. The FDA added it in December 2024. The label requires a liver blood test before you start, then again monthly for the first three months, and again at months six and nine. You should not start Veozah if your ALT or AST is at least twice the upper limit of normal, or if your bilirubin is at least twice the upper limit of normal. This is exactly why so many plans demand lab work in the prior authorization. See our full Veozah liver warning guide.

The labs your packet needs

The standard panel covers ALT, AST, ALP, and bilirubin (total and direct) — the liver blood tests. Many plans want these done before you start, and want them below 2× the normal limit. Get them done early; a missing or stale lab is one of the most common reasons a Veozah request stalls.

Who can’t start Veozah

Per the FDA label, Veozah is not for people with:

Cirrhosis — Serious liver scarring
Severe kidney disease or end-stage kidney disease
Use of a CYP1A2 inhibitor — A type of medicine that slows how your body clears Veozah. If you take estrogen or any regular medication, your prescriber should check it against this list before you start.

Signs to stop and call your doctor

The FDA-approved label says to stop Veozah right away and seek medical care if you notice new tiredness, loss of appetite, nausea, vomiting, itching, yellow skin or eyes, pale stools, dark urine, or belly pain. These can be signs of liver trouble.

Here’s the quiet upside: a request that includes your labs and a monitoring plan isn’t just more likely to get approved — it means someone is actually watching your liver while you take a drug that needs watching. That’s a feature, not a hassle.

Do you have to try hormone therapy first?

Sometimes yes, sometimes no — it depends on your plan. Plans with step therapy may ask whether you tried hormone therapy and it failed, whether you couldn’t tolerate it, or whether your clinician decided it’s not safe for you. Some plans also want you to have tried an older non-hormonal medicine — like an SSRI, SNRI, or gabapentin — before they’ll cover Veozah.

“Step therapy” just means the plan wants proof you tried or couldn’t use a cheaper or preferred option first. It feels like a roadblock. It’s really a documentation problem.

A few real examples from the policies we read:

TRICARE: The US Family Health Plan (a TRICARE plan) asks whether you can’t take hormone therapy (a contraindication, an intolerance, or a provider’s judgment that you’re not a candidate) and whether you tried and failed an SSRI, SNRI, or gabapentin.
West Virginia: West Virginia Medicaid wants a 30-day hormone therapy trial plus a 30-day non-hormonal trial — or two non-hormonal trials if hormones aren’t an option.
Prime: Prime Therapeutics counts a few things as meeting the hormone step, including being over 60 or being more than 10 years past the start of menopause.

One important caution

Don’t try to declare your own contraindication. If hormone therapy genuinely isn’t right for you, your clinician needs to document the medical reason. That documentation is what makes a step-therapy approval work.

Where do you get the Veozah prior authorization form?

The form almost always comes from your insurance plan, its pharmacy benefit manager, or your prescriber’s portal — and your prescriber submits it, not you. There’s no single national “Veozah form.” Astellas also publishes free prior-authorization resources for clinicians, including a checklist, a sample Letter of Medical Necessity, and the relevant ICD-10 codes, but it’s your plan’s own form and rules that control the decision.

Two ways to get the right form fast:

Ask your plan directly(use the call script above) — request the exact Veozah PA form and where to send it.
Ask your prescriber’s office— many clinics can pull your plan’s form through their e-prescribing or portal system.

If your prescriber wants templates to work from, point them to VEOZAH Support Solutions, which provides a coverage-request letter, a denial-appeal letter, and a formulary-exception letter for clinicians to customize. These are starting points for your doctor to tailor to your records — not forms you fill out alone.

Why was my Veozah prior authorization denied?

A Veozah denial usually means one of six things: the request was incomplete, step therapy wasn’t documented, the plan says Veozah isn’t covered, liver labs were missing, the diagnosis or severity wasn’t clear, or the prescription exceeded the quantity limit. Get the written denial reason before you do anything else — your fix depends entirely on which one it is.

What the denial says	What it probably means	What to ask for next
Prior authorization required	No request was sent, or it’s incomplete	The plan’s Veozah PA form and its written criteria
Step therapy required	The plan wants proof of a prior treatment	Your trial history, or a clinician’s contraindication note
Non-formulary	Veozah isn’t on the covered drug list	The formulary exception process
Not medically necessary	The packet didn’t match the plan’s rules	A Letter of Medical Necessity plus chart notes
Missing information	The office left out labs, a code, or notes	The exact missing field — then resend
Quantity limit	The plan covers less than prescribed	Confirm the dose is one tablet daily

How do you appeal a Veozah denial?

Start by getting the written denial letter, your plan’s Veozah criteria, the appeal deadline, and how to submit (fax or portal). Then have your prescriber send an appeal that directly answers the reason for the denial — not the same incomplete request again.

Here’s the part worth sitting with: in 2024, of roughly 85 million denied in-network claims on the ACA marketplace, fewer than 1% were appealed (KFF). Almost nobody fights back. Now the honest balance: when people do appeal, insurers upheld about 66% of those appealsin 2024. So an appeal isn’t a magic reversal — roughly a third get overturned, not most. But you can’t be in that third if you never file. And it helps to know what the denials are even about: in that same data, only 5% of denials were for “not medically necessary”— the rest were largely administrative. In plain terms, a lot of “no” is paperwork, not a judgment on your case.

So appeal smart. Here’s the playbook.

Step 1

Get the denial letter

You’re entitled to a written reason. Ask: “Is this a prior authorization denial, a step therapy denial, a formulary exclusion, a quantity-limit denial, or a missing-information denial?”

Step 2

Get the plan’s criteria

Then mirror their exact wording. If the plan asks for “moderate-to-severe VMS due to menopause,” your appeal should use that phrase — not “really bad hot flashes.”

Step 3

Build the appeal packet

• Your diagnosis and that Veozah is FDA-approved for it
• The exact denial reason, answered directly
• The specific plan criterion you’re meeting
• Symptom frequency and severity
• Your prior treatment history — or the documented reason you can’t use hormone therapy
• Baseline liver labs and your monitoring plan
• Your medication list (to clear the interaction screen)
• The requested dose and quantity (one tablet daily)
• Attachments: the denial letter, chart notes, and lab results

Step 4

Use the manufacturer’s free templates

VEOZAH Support Solutions provides sample letters your clinician can customize — a Letter of Medical Necessity, a denial-appeal letter, and a formulary-exception request. Built for your doctor to tailor, not to send as-is.

Step 5

Watch the clock

Deadlines vary by plan — for many plans you have up to 180 days to file an internal appeal, and urgent cases can sometimes get a decision in about 72 hours. The exact deadline is in your denial letter, so don’t guess.

What if you don’t have a doctor who’ll handle this?

Not everyone has a menopause specialist — or a prescriber whose office will chase down a prior authorization. Maybe you got your Veozah prescription from a rushed visit, or the office submitted somethingweeks ago and went quiet. If that’s you, a telehealth menopause clinic that takes insurance and prescribes through it can be a real path forward.

For that situation, we point readers to Midi Health— and we’ll give you the verified facts, including one real reason it won’t work for everyone.

Midi Health — insurance-based menopause care in all 50 states

✓Available in all 50 states, with insurance coverage for virtual visits and prescriptions
✓In-network with most — though not all — PPO plans; you typically just pay a specialist copay
✓Clinicians trained specifically in menopause care, overseen by menopause physicians
✓Offers both hormonal and non-hormonal treatments, including fezolinetant (Veozah) within their scope
✓Prior authorizations handled the way any in-network doctor’s office handles them
✓Lab work ordered as part of your Care Plan — the baseline and follow-up liver tests Veozah calls for fit right into how they already work

The honest limit — and it’s a real one: Midi does not accept Medicaid or Medi-Cal, not even if you offer to pay cash. And Midi is not covered by Medicare; Medicare members can only be seen as self-pay, with no claims submitted. If you’re on Medicaid or Medicare, Midi isn’t your path — your plan’s own prior authorization process, run through your current prescriber, is. Everything else in this guide still works for you.

Disclosure: we may earn a commission if you start care through this link, at no extra cost to you. Our checklist, criteria table, and verification are independent of that.

Check whether Midi is in-network with your insurance →

See your coverage and book a visit with a menopause-trained clinician who can evaluate whether Veozah is right for you and prescribe through your plan.

How much does Veozah cost if the prior authorization is approved?

Your cost depends on your plan, pharmacy, deductible, and savings eligibility. The list price is $583.50 a month as of January 14, 2026 — but Astellas says most patients don’t pay that. With commercial insurance plus the manufacturer’s savings card, eligible patients may pay $0 the first month and as little as $30 per refill. Government plans like Medicare and Medicaid can’t use that card.

The savings-card detail almost no one mentions

The VEOZAH Savings Card can bring eligible commercially insured patients down to $0 the first month and around $30 per refill, up to $4,000 in help per year.

Critical detail: the card only works once your PA goes through

If your commercial plan does not approve the Veozah claim, Astellas may cut that assistance down to a maximum of $1,250 for two months.Astellas itself tells prescribers to submit the prior-authorization paperwork as early as possible “to ensure patients can use the savings card.” Translation: the card only delivers its full value once your prior authorization goes through. Get the approval first, then apply the card. Chase the card before the approval and you can leave most of that $4,000 on the table.

If you have Medicare or Medicaid

The manufacturer copay card is off-limits for any government plan — Medicare, Medicaid, TRICARE, and VA included. If that’s you, lean on your plan’s own coverage (with the prior authorization) and call VEOZAH Support Solutions to ask what assistance you may qualify for.

If you’re uninsured

Astellas says eligible uninsured patients may pay $0 through its Patient Assistance Program. You apply through VEOZAH Support Solutions. For the full cost breakdown across every situation, see our Veozah cost without insurance guide.

Commercial insurance vs. Medicare vs. Medicaid: what changes?

The biggest differences are the savings card and the rules. Commercial plans may let you use the manufacturer copay card if you meet the terms. Medicare and Medicaid can’t use it at all. And Medicaid rules change state by state — as our table shows, Texas approves with no step therapy while West Virginia wants two separate trials first.

Commercial / employer plans

Most likely to cover Veozah — Astellas reports about 8 in 10 commercially insured people have access (based on 88% of commercial covered lives as of December 2025, not counting the Health Insurance Marketplace). That access usually comes with a prior authorization and sometimes step therapy. The savings card may apply if you qualify.

Medicare Part D

Coverage varies by plan, and prior authorization is common. For Part D drug requests, plans must decide standard requests within 72 hours and urgent ones within 24 hours. The savings card does not apply.

Medicaid

Coverage and rules vary by state. Many states publish their own Veozah criteria (we read five). The savings card does not apply.

One firm rule: never try to use a commercial manufacturer savings card with Medicare or Medicaid. The terms prohibit it.

What if Veozah isn’t covered at all?

If your plan excludes Veozah outright, a standard prior authorization won’t fix it — you’ll need a formulary exception or an appeal instead. And if coverage still doesn’t come through, that’s the moment to talk with your clinician about other options rather than quietly paying full price month after month.

A formulary exception is a request to cover a drug that isn’t on your plan’s list, usually because the covered options won’t work for you. It’s a different process than a standard PA, and your prescriber drives it.

If Veozah turns out not to be the right path, your clinician might discuss other routes — hormone therapy, another FDA-approved non-hormonal option like Lynkuet (elinzanetant), or older non-hormonal medicines. See our guide to non-hormonal options for menopause for a full comparison.

Not sure whether to fight the denial or look at another option?

Take our free 60-second matching quiz and get a personalized action plan you can bring to your clinician.

Get my personalized action plan \u2192

How do you renew a Veozah prior authorization?

Renewals focus on whether Veozah is still working and still safe. Most plans want proof your hot flashes improved, that your liver monitoring is up to date, and that you haven’t had problems that would stop treatment. Approval lengths vary — many plans renew for 12 months, while the US Family Health Plan form approves renewals indefinitely after your first approval.

What your renewal packet typically needs:

Your symptom response — ideally a before-and-after on how often and how badly you get hot flashes
Confirmation you still need it
Your liver lab monitoring record
No problems serious enough to stop treatment
Current medication list and the same one-tablet-a-day dose

This is why we said it at the top: track your hot flashes from day one.A renewal that says “down from 9 episodes a day to 2” is an easy approval. “Feels better, I think” is not.

Ask your plan and your prescriber how early you can submit a renewal so your coverage doesn’t lapse between fills.

Frequently asked questions

Does Veozah require prior authorization?

Most plans require it, and some also require step therapy (trying another treatment first). The only way to know your situation is to ask your plan for the exact reason your claim was rejected and request its written criteria.

What ICD-10 code is used for Veozah?

Payer rules and Texas Medicaid criteria point to N95.1, “menopausal and female climacteric states.” Your clinician handles the coding, but it helps to know which code appears in the policies.

What liver tests are needed for Veozah prior authorization?

The FDA label calls for a liver blood test (ALT, AST, ALP, bilirubin) before you start, then monthly for the first three months, and again at months six and nine. You shouldn’t start Veozah if your ALT or AST is at least twice the upper limit of normal, or if your bilirubin is at least twice the upper limit of normal.

Can I use the Veozah savings card with Medicare or Medicaid?

No. Astellas states the savings card cannot be used for prescriptions paid in whole or in part by any government program, including Medicare, Medicaid, TRICARE, and VA.

My Veozah was denied because I didn’t try estrogen first — now what?

Some plans require a prior hormone therapy trial, or a documented medical reason you can’t take it. Ask your clinician to document the reason; don’t try to certify a contraindication yourself.

Can the manufacturer help with the prior authorization?

Yes. VEOZAH Support Solutions provides PA checklists, a sample Letter of Medical Necessity, denial-appeal and formulary-exception templates for your clinician to customize, plus patient-assistance options.

How long does a Veozah prior authorization take?

It depends on your plan. Many plans decide standard requests within about a week and urgent ones within 72 hours; Medicare Part D plans must decide standard drug requests within 72 hours and urgent ones within 24 hours. You’ll usually hear through your pharmacy, your prescriber, or a letter from your plan.

Is Veozah hormone therapy?

No. Veozah (fezolinetant) is a non-hormonal medicine for moderate-to-severe hot flashes and night sweats due to menopause. It works on a brain signal that triggers hot flashes, not on your hormones.

How this guide was built

We built this page from primary sources, not summaries. Safety and dosing facts come from the FDA label and the FDA’s Drug Safety Communication. Pricing and savings terms come from Astellas. Prior-authorization criteria come from ten payers’ own policy documents. The appeal-rate figures come from KFF’s analysis of 2024 federal marketplace data. We used patient forums only to understand the language and frustration people experience — never as medical or coverage evidence. The checklists and the cross-insurer pattern are our own analysis.

A few things we did notverify, and you should confirm for your own case: whether your specific plan covers Veozah today, whether you personally qualify, and whether any particular clinic will submit your paperwork. Coverage rules change — we re-check this page on a set schedule and update the “last verified” date when we do. Last verified: June 16, 2026.

Still not sure which HRT program is right for you?

Take our free 60-second matching quiz. You’ll get a clear, personalized next step.

Take the free 60-second quiz \u2192

Related guides

Sources

1.FDA — Drug Safety Communication and Boxed Warning, serious liver injury with Veozah (fezolinetant) (Sept 2024; Boxed Warning added Dec 16, 2024). https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-veozah-fezolinetant-about-rare-risk-serious-liver-injury
2.Veozah (fezolinetant) Prescribing Information, Astellas. https://www.astellas.com/us/system/files/veozah_uspi.pdf
3.Astellas — Wholesale Acquisition Cost disclosure (Veozah 45 mg, 30 tablets, $583.50 as of Jan 14, 2026). https://www.astellas.com/us
4.VEOZAH savings, support, and coverage (incl. ~8 in 10 / 88% commercial access as of Dec 15, 2025). https://www.veozah.com/savings
5.VEOZAH Support Solutions — patient and prescriber resources. https://veozahsupportsolutions.com/
6.KFF — Claims Denials and Appeals in ACA Marketplace Plans in 2024. https://www.kff.org/private-insurance/issue-brief/claims-denials-and-appeals-in-aca-marketplace-plans/
7.Prime Therapeutics / Accord — Vasomotor Symptoms PA criteria (eff. Jan 1, 2026). https://www.primetherapeutics.com
8.CVS Caremark — Veozah PA criteria. https://www.caremark.com
9.UnitedHealthcare — Veozah commercial medical-necessity policy. https://www.uhcprovider.com
10.Western Health Advantage — pharmacy PA criteria. https://www.westernhealth.com
11.US Family Health Plan (TRICARE) — Veozah PA form, Johns Hopkins Health Plans. https://www.hopkinsmedicine.org
12.Alaska Medicaid — Veozah PA criteria. https://health.alaska.gov
13.West Virginia, Mississippi, Minnesota Medicaid — Veozah PA criteria (state policies on file). https://medicaid.ms.gov
14.Texas Medicaid — Veozah / vasomotor symptoms clinical criteria (Acentra). https://paxpress-txpa.acentra.com
15.Medicare Part D coverage determination timelines, CMS; Midi Health — coverage, insurance limits, and clinical scope. https://www.cms.gov

The HRT Index is an independent comparison resource for HRT telehealth providers. This article is general information, not medical advice — talk with a licensed clinician about your situation. We may earn a commission if you start care through some links, at no extra cost to you, and our verification and recommendations are independent of any commission. Last verified: June 16, 2026.